D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KDNY holding history
Chinook Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KDNY overviewAll 13F holders of KDNYFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −282,154−100.0% | Sold out | Holders |
| Q2 2023 | 282,154 | $10.8M | <0.1% | −37,552−11.7% | Reduced | Holders |
| Q1 2023 | 319,706 | $7.40M | <0.1% | −40,079−11.1% | Reduced | Holders |
| Q4 2022 | 359,785 | $9.43M | <0.1% | −119,742−25.0% | Reduced | Holders |
| Q3 2022 | 479,527 | $9.43M | <0.1% | +225,945+89.1% | Added | Holders |
| Q2 2022 | 253,582 | $4.43M | <0.1% | +191,135+306.1% | Added | Holders |
| Q1 2022 | 62,447 | $1.02M | <0.1% | −65,655−51.3% | Reduced | Holders |
| Q4 2021 | 128,102 | $2.09M | <0.1% | +95,966+298.6% | Added | Holders |
| Q3 2021 | 32,136 | $410.0K | <0.1% | +32,136 | New | Holders |